1.Pv Liquid FDA
1.Pv Liquid FDA
1.Pv Liquid FDA
By
Weerayut Chirarutsami
23/08/2006 1
Process Validation
2
Process Validation
Process Validation is :
Documented
3
Process Validation
4
Process Validation
5
Process Validation
Type of Process Validation
Retrospective
Based on accumulated historical production, testing and
control data
Generally requires data from 10-30 batches
Use data only from batches made by the same process
Prospective
Conducted prior to market the product
Concurrent
Based on information generated during actual implementation
of the process (each batch will be released separately) 6
Re-validation
Re-validation provides the evidence that changes in a
process and/or the process environment, introduced
either intentionally or unintentionally, do not adversely
affect process characteristics and product quality.
There are two basic categories of Re-validation:
Re-validation in cases of known change (including transfer
of processes from one company to another or from one
site to another),
Periodic Re-validation carried out at scheduled intervals.
7
Re-validation in cases of known change
10
Periodic Re-validation
The following points should also be considered:
The occurrence of any changes in the master formula,
methods or starting material manufacturer
Equipment calibrations carried out according to the
established program
Preventative maintenance carried out according to the
program
Standard operating procedures (SOPs) up to date and being
followed
Cleaning and hygiene program still appropriate,
Unplanned changes or maintenance to equipment or
instruments.
11
Validation of Liquid Solution and Suspension
Solution :
A homogenous liquid system in which the active
ingredient is completely solubilized
Suspension :
A heterogeneous liquid system consisting of two
phases. The continuous or external phase is generally
a liquid or semisolid, and the dispersed or internal
phase is made up of the particulate matter that is
essentially insoluble in, but dispersed throughout the
continuous phase
12
Validation of Liquid Solution and Suspension
Pre-validation Requirements :
Preventive Maintenance for Facilities and Utilities
Calibration of Equipment
Cleaning Validation
Equipment Qualification
Raw Materials/Components/Test Methods
Process Justification
Change Control
Training operators
All must be proven suitable and reliable for the manufacturing process
before the process can be validated
14
Validation of Liquid Solution and Suspension
Process Justification:
To identify critical process steps & process parameter
For Suspension, settling studies to determine the
acceptable duration that a bulk may sit idle after mixing
Anti-microbial preservative efficacy testing
Uniformity of dosage assay result for the fill containers for
suspension.
To determine the minimum product volume cut-off point
during transfer to filling for suspension using agitated bulk
tank
15
Validation of Liquid Solution and Suspension
Validation Protocol
16
Validation of Liquid Solution and Suspension
18
Critical Parameters
19
Critical Parameters – Liquids
20
Validation of Liquid Solution and Suspension
•Mixing Speed
•Mixing Time
•Cooling Time
•Homogenizing Speed
•Homogenizing Time
22
Validation of Liquid Solution and Suspension
Filtration
pH Adjustment
Final Mixing
23
Validation of Liquid Solution and Suspension
Acceptance Criteria
25
Validation of Liquid Solution and Suspension
Product Testing
Validation testing of bulk and F/G must be based
on testing standard release criteria and in-
process testing criteria
Typically involves non-routine sampling/testing
throughout the entire process, with special
emphasis on critical process parameters.
Routine QC release testing should be performed
on a routine sample. These samples should be
taken separately from the validation samples.
26
Validation of Liquid Solution and Suspension
Validation Batch:
New product and product transfer, Prospective validation is
required
Manufacturing Process, Formula, Equipment and Batch Size
have to be fixed during the validation trials.
Batch Size should be the same size as commercial production
batch
The batch size must be fixed for production. However, it can be
changed up to 10% with the on-going study by using the same
equipment.
Different lots but same manufacturer of active ingredients
should be used during validation trials. 27
Validation of Liquid Solution and Suspension
Validation Batch:(Continued)
Matrixing by batch size is permitted if using the same equipment.
2 batches of the largest batch size + 1 batch of the smallest batch size
For Suspension, the difference in batch size must not greater than
50% of the smallest batch size. ( 2 batches of 750 L + 1 batch of 500 L)
For Solution, the difference in batch size must not greater than 100%
of the smallest batch size. ( 2 batches of 1000 L + 1 batch of 500 L)
28
Validation of Liquid Solution and Suspension
Validation Batch:(Continued)
For Suspension, 1 entire bulk should filled in to 1 batch of the
smallest container size to demonstrate the largest filling run time.
For Solution, the product having more concentration (using same
batch size, same equipment, process parameters, we can validate
only the highest concentration.
For Solution, the lowest filled volume must be validated at least 2
lots and the highest filled volume must be validated at least 1 lot.
29
Sampling Plan &
Acceptance Criteria
30
Validation of Liquid Solution and Suspension
31
Validation of Liquid Solution and Suspension
33
Validation of Liquid Solution and Suspension
Sampling
Solution
Take samples from the beginning, middle and end of
the filling run for assay
Suspension
Suspension bulk should be continuous mixing during
filling operation
Samples must be representative of each filling nozzle
Samples tested for validation must equal or exceed
what is required for routine release
34
Validation of Liquid Solution and Suspension
Sampling
Suspension
For single filling size
Take 10 samples each at the beginning, middle and end of
the filling run. All samples must be tested
Multiple filling size
Take 10 samples each at the beginning, middle and end of
the filling size.
Multiple Tanks and Multiple filling size
Take 10 samples each at the beginning and end of the filling
tank and take 10 samples each at the beginning and end of
the filling size. 35
Validation of Liquid Solution and Suspension
Testing
Net Content
Take samples from the beginning, middle and end of the
filling run. Perform testing per testing standard
Microbiology
Take 3 samples which represent beginning, middle and end
of the filling run. Perform testing per testing standard
Appropriated antimicrobial preservative efficacy testing is
required.
36
Establishing Bulk Homogeneity
Acceptance Criteria: Solutions
Product Acceptance
Sampling Plan
Parameters Criteria
UPL & LPL within 90
– 110% LA*
2 replicate samples from
Bulk
top, middle and bottom
Homogeneity
RSD ≤ 2.0% (test 3 samples)
37
Establishing Bulk Homogeneity
Acceptance Criteria: Suspensions
Product Acceptance
Sampling Plan
Parameters Criteria
UPL & LPL within 90
– 110% LA*
2 samples** each from
Bulk
two levels of 3 locations
Homogeneity
RSD ≤ 3.6% each (test 6 samples)
38
RSD Limits for Bulk Samples
39
RSD Limit Criteria
1
UPL = x + t 0 . 025 ,n − 1 s 1+
n
1
110 = 100 + t 0 . 025 ,2 s 1+
3
10 = 4 . 3027 * s * 1 . 1547
s = 2 . 01 40
Filled Product: Content Uniformity
– Solutions
41
Filled Product: Content Uniformity
– Suspensions (low potency)
* Product Specs
42
Filled Product: Content Uniformity –
Suspensions (medium potency)
* Product Specs
43
Validation of Liquid Solution and Suspension
Validation Report
Validation Team must prepare the report
Report must be reviewed and approved by QA.
Written Notification or either successful completion or
failure of the process validation must be issued to top
management.
In case of failure, an investigation must be completed
and documented prior to repeat the validation study.
44
Validation of Liquid Solution and Suspension
45
Validation of Liquid Solution and Suspension
Changes
Minor: It seems to have no impact on formulation
It is not necessary to validate
Intermediate : It could have significant impact on formulation
Depend on case-by-case (A minimum of 1 trial)
Major : It is likely to have significant impact on formulation
Revalidation is required (A minimum of 3 trials)
46
Validation of Liquid Solution and Suspension
Minor Change
Delete or Decrease quantity of colorant, flavor
Qualitative inactive excipient change deemed minor by
change control review
Process change deemed minor by change control review
For solution, Change in batch size of ≤ 100% using the
same equipment
Manufacturing location change with in same building, same
equipment, personnel, procedure and utilities are used
Equipment change but same design, configuration
47
Validation of Liquid Solution and Suspension
Intermediate Change
Active ingredient source or synthesis change deemed
intermediate by change control review
Qualitative inactive excipient change deemed intermediate
by change control review
Change in batch size 100% < batch size ≤ 200% for
solutions.
Change in batch size of ≤ 50% for suspension
Manufacturing location change to a different building on the
same site and same utilities, same equipment, personnel,
and procedure are used
48
Validation of Liquid Solution and Suspension
Intermediate Change
Process changes, such as mixing times or operating
speeds for solutions.
Change in release specification to a tighter limit caused
original validation results to be out of specification
Extension of the qualified in process hold time for
intermediate or finished product prior to packaging
Equipment change deemed intermediate by change control
review
49
Validation of Liquid Solution and Suspension
Major Changes
Quantitative or qualitative formulation change deemed major by
change control review
Inactive excipient or active ingredient source change deemed
major by change control review
Transfer product from on site to another
Significant change in process
Change in batch size > 200% for solutions.
Change in batch size > 50% for suspensions.
50
Validation of Liquid Solution and Suspension
Major Changes
Equipment change to a different design, configuration or
operating principle.
New Dosage
Rework Procedure
Process changes deemed major by change control review
such as mixing times or operating speeds for suspensions.
Change in release specification to a tighter limit caused
original validation results and routine production results to be
out of specification
51
Validation of Liquid Solution and Suspension
Conclusion
Process must be continually monitored and change
control used to identify need for process revalidation
Validation Protocol identifies critical process
parameters to be evaluated and predetermined
acceptance criteria
Production and QA have to review and approve the
validation result
Product must be held until the validation get approval
52